Garcia J G, Fenton J W, Natarajan V
Department of Medicine, Indiana University School of Medicine, Indianapolis.
Blood. 1992 Apr 15;79(8):2056-67.
The activation of membrane-bound phospholipase D (PLD) resulting in the generation of phosphatidic acid (PA) is increasingly recognized as an integral event in the initiation of a variety of cellular responses. We explored whether alpha-thrombin is a physiologic agonist for PLD activation in human umbilical vein endothelial cells (HUVEC). HUVEC monolayers were labeled with [32Pi] and PLD activity determined by formation of the PLD metabolite [32P] phosphatidylethanol (PEt) in the presence of 5 g/L ethanol by thin-layer chromatography. alpha-Thrombin rapidly (1 minute) increased PA and PEt formation in a dose-dependent manner (10(-6) to 10(-10)) with maximal PLD stimulation achieved with 10 nmol/L alpha-thrombin producing a threefold to fourfold increase in PA and a sixfold to eightfold increase in PEt over controls at 15 minutes. Esterolytically active zeta-thrombin (10 nmol/L) and gamma-thrombin (1 mumol/L), but not inactive DIP-alpha-thrombin (1 mumol/L) also increased PLD activity. The role of Ca2+ flux in human endothelial cell PLD activation was investigated and PEt formation was significantly enhanced by Ca2+ ionophores A23187 and ionomycin (1 mumol/L, three-fold to fourfold increase in PEt). Alpha-Thrombin-stimulated PEt formation was abolished (greater than 90% inhibition) with chelation of intracellular calcium (Ca2+i) by pretreatment with BAPTA-AM (25 mumol/L, 30 minutes) but only mildly attenuated (30% inhibition) by removal of extracellular calcium (Ca2+E) with EGTA (5 mmol/L). The protein kinase C (PKC) inhibitor staurosporine reduced alpha-thrombin-induced PEt formation in a dose-dependent manner (10 mumol/L, 78% inhibition) and PKC downregulation with chronic PMA treatment (18 hours) also resulted in marked inhibition of alpha-thrombin-induced PEt formation. Neither pertussis nor botulinum C bacterial toxins significantly altered alpha-thrombin-induced PLD responses. In contrast, similar pretreatment with cholera toxin (1 microgram/mL, 60 minutes) consistently augmented alpha-thrombin-stimulated PLD activity by 50% to 90%. Comparable results were observed with agents which increased cAMP such as forskolin, 8-bromo cAMP, or dibutyryl cAMP and cholera toxin augmentation was abolished by 2-dideoxyadenosine, a competitive inhibitor of adenylyl cyclase activity. These studies demonstrate that alpha-thrombin is a potent stimulus for human PLD-mediated PA formation and that cyclic adenosine nucleotides modulate agonist-induced cellular PLD activity. In this model of PLD activation, alpha-thrombin receptor occupancy leads to the breakdown of phosphatidylinositol 4,5-bisphosphate catalyzed by phospholipase C producing the Ca2+ secretagogue IP3 and DAG.(ABSTRACT TRUNCATED AT 400 WORDS)
膜结合磷脂酶D(PLD)的激活导致磷脂酸(PA)的生成,这一过程日益被认为是引发多种细胞反应不可或缺的环节。我们探究了α-凝血酶是否是人类脐静脉内皮细胞(HUVEC)中PLD激活的生理激动剂。用[32P]标记HUVEC单层细胞,并通过在5 g/L乙醇存在下,利用薄层色谱法测定PLD代谢产物[32P]磷脂酰乙醇(PEt)的生成来确定PLD活性。α-凝血酶迅速(1分钟)以剂量依赖性方式(10(-6)至10(-10))增加PA和PEt的生成,10 nmol/L的α-凝血酶可实现最大PLD刺激,在15分钟时,PA增加三至四倍,PEt增加六至八倍,超过对照组。具有酯解活性的ζ-凝血酶(10 nmol/L)和γ-凝血酶(1 μmol/L),但无活性的DIP-α-凝血酶(1 μmol/L)也可增加PLD活性。研究了Ca2+通量在人类内皮细胞PLD激活中的作用,Ca2+离子载体A23187和离子霉素(1 μmol/L,PEt增加三至四倍)可显著增强PEt的生成。通过用BAPTA-AM(25 μmol/L,30分钟)预处理螯合细胞内钙(Ca2+i),可消除α-凝血酶刺激的PEt生成(抑制率大于90%),但用EGTA(5 mmol/L)去除细胞外钙(Ca2+E)仅使其轻度减弱(抑制率30%)。蛋白激酶C(PKC)抑制剂星形孢菌素以剂量依赖性方式降低α-凝血酶诱导的PEt生成(10 μmol/L,抑制率78%),用慢性佛波酯(PMA)处理(18小时)下调PKC也可显著抑制α-凝血酶诱导的PEt生成。百日咳毒素和肉毒杆菌C型细菌毒素均未显著改变α-凝血酶诱导的PLD反应。相反,类似的霍乱毒素预处理(1 μg/mL,60分钟)可使α-凝血酶刺激的PLD活性持续增强50%至90%。用增加cAMP的试剂如毛喉素、8-溴cAMP或二丁酰cAMP也观察到类似结果,腺苷酸环化酶活性的竞争性抑制剂2-脱氧腺苷可消除霍乱毒素的增强作用。这些研究表明,α-凝血酶是人类PLD介导的PA形成的有效刺激物,环腺苷酸核苷酸调节激动剂诱导的细胞PLD活性。在这个PLD激活模型中,α-凝血酶受体占据导致磷脂酶C催化磷脂酰肌醇4,5-二磷酸分解,产生Ca2+促分泌剂IP3和二酰甘油。(摘要截断于400字)